Patents matching “MENS”

EP 1683416

Alkoholische Zusammensetzungen zum Desinfizieren

AIR LIQUIDE SANTE INT [FR] · Granted Jul 26, 2006 · Expires Jul 21, 2026

EP 1683417

Desinfizierende Zusammensetzungen enthaltend Glycerin-Monoalkylethern und Bis-Pyridiniumalkanen und deren Verwendung als Hautantiseptika

AIR LIQUIDE SANTE INT [FR] · Granted Jul 26, 2006 · Expires Jul 21, 2026

EP 1683418

Zusammensetzungen zum Desinfizieren und Waschen der Händen

AIR LIQUIDE SANTE INT [FR] · Granted Jul 26, 2006 · Expires Jul 21, 2026

US 6900027

Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays

Precision Therapeutics, Inc. · Granted May 31, 2005 · Expires May 26, 2025

EP 1526849

TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON

MENARINI FARMA IND [IT] · Granted May 4, 2005 · Expires Apr 29, 2025

US 6889145

Three-dimensional model of a Fc region of an IgE antibody and uses thereof

Northwestern University · Granted May 3, 2005 · Expires Apr 28, 2025

US 6887680

Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays

Precision Therapeutics, Inc. · Granted May 3, 2005 · Expires Apr 28, 2025

US 6872387

Three-dimensional hydrogel/cell system

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 29, 2005 · Expires Mar 24, 2025

US 6820011

Three-dimensional structure of complement receptor type 2 and uses thereof

The Regents of the University of Colorado · Granted Nov 16, 2004 · Expires Nov 11, 2024

US 6759408

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Jul 6, 2004 · Expires Jul 1, 2024

EP 1392755

ZUSAMMENSETZUNGEN ENTHALTEND LIPID-POLYMER KONJUGATE

YAMANOUCHI EUROP BV [NL] · Granted Mar 3, 2004 · Expires Feb 27, 2024

EP 1381397

STABILISIERUNG VON RADIOPHARMAZEUTISCHEN ZUSAMMENSETZUNGEN MIT EINEM HYDROPHILEN THIOETHER ODER EINEM HYDROPHILEN 6-HYDROXY-CHROMAN

DIATIDE INC [US] · Granted Jan 21, 2004 · Expires Jan 16, 2024

WO 03105839

VERWENDUNG VON RIBAVIRIN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG GEGEN BUNYAVIRIDAE

BIOPARTNERS GMBH [CH] · Granted Dec 24, 2003 · Expires Dec 19, 2023

US 6613792

Treatment of premenstrual syndrome and menopause

Designed Nutritional Products, Inc. · Granted Sep 2, 2003 · Expires Aug 28, 2023

AT E245157

3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

BEECHAM GROUP PLC [GB] · Granted Aug 15, 2003 · Expires Aug 10, 2023

US 6544970

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Apr 8, 2003 · Expires Apr 3, 2023

EP 1297826

Pharmazeutische Zusammensetzung zur nasalen Verabreichung enthaltend einen NK-2 Antagonisten

MENARINI RICERCHE SPA [IT] · Granted Apr 2, 2003 · Expires Mar 28, 2023

US 6503939

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Jan 7, 2003 · Expires Jan 2, 2023

US 6498154

Cyclic regimens using quinazolinone and benzoxazine derivatives

Ligand Pharmaceuticals Incorporated · Granted Dec 24, 2002 · Expires Dec 19, 2022

US 6462032

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Oct 8, 2002 · Expires Oct 3, 2022

US 6444668

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Sep 3, 2002 · Expires Aug 29, 2022

US 6399593

Cyclic regimens using cyclic urea and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Jun 4, 2002 · Expires May 30, 2022

US 6380178

Cyclic regimens using cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Apr 30, 2002 · Expires Apr 25, 2022

US 6329416

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Dec 11, 2001 · Expires Dec 6, 2021